World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 May 2023
Main ID:  RBR-8ykyws
Date of registration: 25/06/2015
Prospective Registration: No
Primary sponsor: Faculdade de Medicina de Botucatu
Public title: Effects of physical exercise and vitamin D supplementation on muscle mass of hemodialysis patients
Scientific title: Effects of physical training and vitamin D supplementation on muscle mass of hemodialysis patients
Date of first enrolment: 30/11/2013
Target sample size:
Recruitment status: Recruitment completed
URL:  http://ensaiosclinicos.gov.br/rg/RBR-8ykyws
Study type:  Intervention
Study design:  Prevention, factorial, randomized, controlled, double-blind, 4 arms clinical trial.  
Phase:  N/A
Countries of recruitment
Brazil
Contacts
Name: Barbara Perez   Vogt
Address:  Rubiao Junior, s/n 18618-970 Botucatu Brazil
Telephone: +5519992241340
Email: barbara_pv@yahoo.com.br
Affiliation:  Faculdade de Medicina de Botucatu
Name: Jacqueline Teixeira   Caramori
Address:  Rubiao Junior, s/n 18618-970 Botucatu Brazil
Telephone: +5514997980427
Email: jteixeir@fmb.unesp.br
Affiliation:  Faculdade de Medicina de Botucatu
Key inclusion & exclusion criteria
Inclusion criteria: Individuals older than 18 years; with chronic kidney disease on dialysis for a period greater than or equal to three months; classified as sedentary or irregularly active according to the International Physical Activity Questionnaire (IPAQ); do not have contraindications to physical activity; and accept and sign the Informed Consent.
Exclusion criteria: Individuals unable to understand the procedures performed; prior diagnosis of coronary artery disease; positive exercise test for cardiac ischemia; patients classified as active or very active based on the International Physical Activity Questionnaire; Patients who have suffered stroke; patients with cancer, liver failure, chronic infection or acute in activity; uncontrolled hypertension (> 160 mmHg systolic or > 100 mmHg diastolic); Use of medications that affect body composition, such as corticosteroids and antiretroviral therapy.

Age minimum: 18Y
Age maximum:
Gender: -
Health Condition(s) or Problem(s) studied
Chronic kidney disease, hemodialysis
E02.870.300
C12.777.419.780.750.500
Intervention(s)
D04.808.247.222.159
Other
Group 1: 7 patients on maintenance hemodialysis that will receive Cholecalciferol (vitamin D) suplementation, dose of 50000 UI, once a week for 4 months, capsule orally,and aerobic exercise training on exercise bike (30 minutes three times a week for 4 months);
Group 2: 7 patients on maintenance hemodialysis that will receive orally a capsule of placebo once a week for 4 months, and aerobic exercise training on exercise bike (30 minutes three times a week for 4 months)and aerobic exercise training on exercise bike (30 minutes three times a week for 4 months);
Group 3: 7 patients on maintenance hemodialysis that will receive Cholecalciferol (vitamin D) suplementation, dose of 50000 UI, once a week for 4 months, capsule orally,and will not realize aerobic exercise training;
Group 4: 7 patients on maintenance hemodialysis that will receive orally a capsule of placebo once a week for 4 months, and will not realize aerobic exercise training.
I02.233.543
Primary Outcome(s)
Significant increase in total muscle mass in the assessment before and after intervention period assessed by X-ray absorptiometry dual energy.
Secondary Outcome(s)
Significant increase in lower limbs muscle mass in the assessment before and after intervention period assessed by X-ray absorptiometry dual energy.
Significant increase of overall muscle function in the assessment before and after intervention period assessed by handgrip strength.
Secondary ID(s)
Source(s) of Monetary Support
Hospital das Clínicas da Faculdade de Medicina de Botucatu
Secondary Sponsor(s)
Hospital das Clínicas da Faculdade de Medicina de Botucatu
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history